Feedback / Questions
AUR-103 - Aurigene
AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)
(clinicaltrials.gov)
-
Jun 11, 2026 -
P2 | N=30 | Not yet recruiting | Sponsor: Aurigene Discovery Technologies Limited
New P2 trial
•
Neuroendocrine Tumor • Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT07640737
Jun 11, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next